Close
Phitech
PhiTech provides a multi-omics based, AI-powered clinical diagnostic decision support system for precision medicine applications.
- Founded 2013
- First Invested 2023
- Headquarter Gebze/Kocaeli, Türkiye
- Founders Saliha Durmus Tunahan Cakir Fatih Erdogan Sevilgen
- Investment Manager Selma Bahcivanoglu
- Company web page https://phitech.bio/
Health biotech company PhiTech delivers innovative AI-powered clinical decision support software for molecular diagnostics of rare genetic diseases through a multi-omics approach. It utilizes DNA and RNA sequencing data for more precise and faster diagnosis. It provides a multi-omics-based, AI-powered clinical diagnostic decision support system for precision medicine applications.
The average time for accurate diagnosis of a rare disease is about five years, and the current clinical solution for rare disease diagnosis is genomics, which has lower than 50% success rates. PhiTech incorporates transcriptomics and epigenomics, in addition to genomics, into in-house-developed bioinformatic pipelines and powers them with AI models to increase diagnostic rates.
Saliha Durmus, Co-Founder and CEO
Founded in 2013 by Saliha Durmuş, PhD., Tunahan Çakır, Prof., Fatih Erdoğan Sevilgen, Prof., Saliha and her academic co-founders started PhiTech Bioinformatics based on her PhD thesis on pathogen-host interaction (Phi), which evolved into multi-omics diagnostic solutions. Saliha left academics in 2020 to focus on a bio-entrepreneurship career with the ambition to transmit scientific discoveries into technological clinical solutions. Saliha holds BSc, MSc, and PhD degrees in Chemical Engineering from Boğaziçi University, specializing in Bioinformatics and Systems Biology. She won the Best Doctoral Thesis Award in 2013.
Saliha's experiences as a COO in an industrial biotechnology startup company for two years (2018-2020) and as Plant Manager in the same company for eight months during the production plant construction contributed to her business development and executive skills. In 2021, she received the national TOYP (Ten Outstanding Young Persons) award from JCI (Junior Chamber International) in "Business, Economic and Entrepreneurial Accomplishment." She has a 16-year-old daughter, Zuhal. Saliha is a bookworm who loves to read about science and technology.
Contact now
Saliha's experiences as a COO in an industrial biotechnology startup company for two years (2018-2020) and as Plant Manager in the same company for eight months during the production plant construction contributed to her business development and executive skills. In 2021, she received the national TOYP (Ten Outstanding Young Persons) award from JCI (Junior Chamber International) in "Business, Economic and Entrepreneurial Accomplishment." She has a 16-year-old daughter, Zuhal. Saliha is a bookworm who loves to read about science and technology.
